课题基金 / 基金详情

The application of diagnosis and treatment of Angiopoietin and Ephrin from retinal ischemia in the angiogenesis

The application of diagnosis and treatment of Angiopoietin and Ephrin from retinal ischemia in the angiogenesis
血管生成素和Ephrin在视网膜缺血血管新生诊治中的应用
批准号:
12671696
负责人:
KISHI Shouji
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

KISHI Shouji的其他基金

相似基金

相关文献

中文摘要
翻译
血管新生通过视网膜血管循环障碍引起视网膜缺血。许多细胞因子如血管内皮生长因子(VGEF)与血管生成有关。为了诱导继发于视网膜缺血的发红和新生血管形成,在3只日本猴的6只眼睛中用激光光凝法阻塞主要视网膜静脉。分别于光凝后1周、2周、4周行眼球摘除术。免疫组织化学分析进行固定石蜡切片的虹膜,小梁和视网膜新生血管,使用多克隆抗体Ephrin-B2,Eph-B4,血管生成素-2和VEGF。抗体定位采用anavidin-biotin反应连接氨基乙基卡巴唑显色剂,小梁网和Schlemms管,包括治疗后1,2和4周,显示VEGF阳性染色。Ephrin-B2在治疗后2周和4周的切片中呈阳性染色,但在治疗后1周的切片中染色不确定。Ephrin- B4和Angiopoietin-2在任何切片中均不显著。治疗后1、2、4周,所有视网膜新生血管均显示VEGF阳性染色。1例治疗后2周Ephrin-B2、B4和Angiopoietin-2染色阳性,另1例Ephrin-B4和Angiopoietin-2染色不确定。这是不确定的部分一个星期和四个星期。在实验诱导的红斑和新生血管形成中,Ephrin-B2的表达紧随VEGF的表达。这些数据表明Ephrin-B2的表达,动脉分化,可能在新形成的血管的生长中发挥作用。
英文摘要
Angiogenesis produces retinal ischemia by circulatory disturbance of retinal vessel. Many cytokines such as vascular endothelial grouth factor (VGEF) seem to be related to the angiogenesis. In order to induce rubeosis and neovascularization secondary to retinal ischemia, major retinal veins were occluded with laser photocoagulation in 6 eyes of 3 Japanese monkeys. Two eyes with rubeosis and neovascularization were enucleated one week, two weeks and four weeks respectively after photocoagulation. Immunohistochemical analysis was performed on fixed paraffin sections of the iris, trabeculum and retinal neovascularization using polyclonal antibody against Ephrin-B2, Eph-B4, Angiopoietin-2 and VEGF. Antibody localization was examined using anavidin-biotin reaction linked to aminoethylcarbabazole color reagent the trabecular meshwork and the Schlemms canal including 1, 2 and 4 weeks after treatment, showed positive staining for VEGF. Ephrin-B2 was positively stained in the section of 2 and 4 weeks after treatment but it was uncertain in the sections of one week. Ephrin- B4 and Angiopoietin-2 were not significant in any sections. All retinal neovascularization 1, 2 and 4 weeks after treatment, showed positive staining for VEGF. One case, Ephrin-B2, B4 and Angiopoietin-2 were positively stained in the section for only 2 weeks after treatment, but other case was uncertain for Ephrin- B4 and Angiopoietin-2. It was uncertain in the sections for one and four weeks. Expression of VEGF was followed by that of Ephrin-B2 in experimentally induced rubeosis and neovasucularization. The data suggests the expression of Ephrin-B2, an arterial differentiation, might play a role in grouth of newly formed vessels.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Takashi Yuki,Yasutaka Kimura Tsugiyasu Kanda etc: "Expression of Ephrins in iris rubeosis in primates eyes"Investigative Ophthalmology and Visual Science. 41・4. 8507 (2000)
Takashi Yuki、Yasutaka Kimura Tsugiyasu Kanda 等:“灵长类动物眼睛虹膜红肿中 Ephrins 的表达”调查眼科和视觉科学 41・4(2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
The role of Activin-Follistatin System in Diabetic Retinopathy
  • 批准号:
    20592032
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2008
  • 负责人:
    KISHI Shouji
  • 依托单位:
国内基金
海外基金
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
  • 批准号:
    82372007
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    谢文晖
  • 依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
  • 批准号:
    82371726
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    李文
  • 依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
  • 批准号:
    32070790
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    徐小燕
  • 依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
  • 批准号:
    81200692
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2012
  • 负责人:
    陈凌
  • 依托单位: